
Soo Young Hwang
@doc_sooyoung
PGY-2 at UMMC Midtown π€ | Harvard MPH 23β | Yonsei Med 21β π°π·
ID: 1054732521852755968
23-10-2018 13:53:24
18 Tweet
55 Followers
101 Following



Checkpoint inhibitors are increasingly common and often highly effective cancer therapies But they can cause hepatitis This systematic review shows: 1 in 6 are steroid refractory 1 in 5 recurs with rechallenge Wei Zhang MD PHD Hepatology Communications journals.lww.com/hepcomm/fullteβ¦

First author Soo Young Hwang

Pharmacotherapy in AUD GI/liver AE in FAERS database with Soo Young Hwang, a PGY-2 IM resident! πππ Love the enthusiasm and work in ALD in medical trainees #TLM24




Grateful for all the attention our project received this #TLM2024! Meeting so many inspiring people gave me more strength to work harder for #liver#research πͺ Shout out to my wonderful mentor Wei Zhang MD PHD who made all of this possible. #HepatologyStrong #ALD #AUD


Read this A review of reported adverse events for medications to treat alcohol use disorder From Soo Young Hwang we must reduce alcohol use in people with liver disease And to increase uptake of useful tools β¦ we need stop repeating that naltrexone is hepatotoxic



π¬π Explore the epidemiology, risk factors, and comprehensive care continuum for HCC in this review in CLINICAL AND MOLECULAR HEPATOLOGY π Read more: shorturl.at/wnEo9 Soo Young Hwang Ju Dong Yang Amit G Singal #livertwitter #gitwitter


#CGH4ALLπ£ π₯ Injectable Naltrexone has an overall better GI and liver safety profile compared to other FDA-approved drugs for Alcohol use disorder (AUD) Wei Zhang MD PHD Soo Young Hwang CGHπ₯!π doi.org/10.1016/j.cgh.β¦Β Reported by Ifrah Fatima Hanna Blaney, MD, MPH Mazen Noureddin, MD, MHSc
